Hypoceruloplasminemia (reduced Cp levels) has been implicated in various neurological disorders, including Wilson’s disease, Alzheimer’s disease, and Parkinson’s disease, where it is associated with abnormal iron metabolism and subsequent neuronal damage (12–14). This evidence concerns the gene CP and nervous system disorder.